Shareholders of Fidson Healthcare Plc have approved a dividend payout of ₦1.50 per 50 kobo ordinary share, translating to a total of ₦3.6 billion. The approval was granted during the company's virtual 27th Annual General Meeting held on Thursday, July 30, 2026.

The dividend distribution follows a historic financial year for the pharmaceutical manufacturer. The company successfully navigated a challenging operating environment to deliver sustainable value to its investors.

Milestone Revenue and Expansion Plans

Fidson recorded a revenue of ₦119.06 billion in 2025, marking a major milestone in the Nigerian pharmaceutical sector. With this performance, Fidson became the first local pharmaceutical company to surpass the ₦100 billion annual revenue threshold.

Founder and Chairman of Fidson, Dr. Fidelis Ayebae, noted that the achievement reflects the dedication of the workforce and the effectiveness of the company's long-term growth strategy. He also expressed gratitude to the Federal Government of Nigeria for implementing strategic policies that support local pharmaceutical manufacturers.

The company is currently executing expansion projects that are in advanced stages. Upon completion, these facilities are expected to position Fidson as the largest and most sophisticated pharmaceutical manufacturing company in Sub-Saharan Africa.

Leadership and Governance Milestones

The AGM also marked the one-year anniversary of the leadership transition at both the board and management levels. Shareholders praised the smooth transition as a reflection of Fidson's strong corporate governance and succession planning.

Managing Director and Chief Executive Officer, Mr. Biola Adebayo, reaffirmed the company's commitment to innovation and manufacturing excellence. He stated that the company will continue to widen its product portfolio, improve market penetration, and leverage emerging opportunities across Africa.

In addition to the dividend approval, shareholders voted on other key resolutions. These included the election and re-election of directors, authorizing the board to fix auditors' remuneration, and electing members of the Statutory Audit Committee.